Cargando…
P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431465/ http://dx.doi.org/10.1097/01.HS9.0000971028.48500.0d |
| _version_ | 1785091209231859712 |
|---|---|
| author | Zhang, Yi Zhang, Qike Liu, Qingchi Dang, Huibing Gao, Sujun Wang, Wei Zhou, Hu Chen, Yuqing MA, Liangming Wang, Jishi Zhao, Peng Yang, Haiping Zhao, Qingwei Suo, Shanshan Jin, Jie |
| author_facet | Zhang, Yi Zhang, Qike Liu, Qingchi Dang, Huibing Gao, Sujun Wang, Wei Zhou, Hu Chen, Yuqing MA, Liangming Wang, Jishi Zhao, Peng Yang, Haiping Zhao, Qingwei Suo, Shanshan Jin, Jie |
| author_sort | Zhang, Yi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431465 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314652023-08-17 P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY Zhang, Yi Zhang, Qike Liu, Qingchi Dang, Huibing Gao, Sujun Wang, Wei Zhou, Hu Chen, Yuqing MA, Liangming Wang, Jishi Zhao, Peng Yang, Haiping Zhao, Qingwei Suo, Shanshan Jin, Jie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431465/ http://dx.doi.org/10.1097/01.HS9.0000971028.48500.0d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, Yi Zhang, Qike Liu, Qingchi Dang, Huibing Gao, Sujun Wang, Wei Zhou, Hu Chen, Yuqing MA, Liangming Wang, Jishi Zhao, Peng Yang, Haiping Zhao, Qingwei Suo, Shanshan Jin, Jie P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title | P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title_full | P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title_fullStr | P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title_full_unstemmed | P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title_short | P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY |
| title_sort | p1033: jaktinib in patients with myelofibrosis who were refractory or relapsed to ruxolitinib: a single-arm, open-label, multicenter, phase 2 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431465/ http://dx.doi.org/10.1097/01.HS9.0000971028.48500.0d |
| work_keys_str_mv | AT zhangyi p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT zhangqike p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT liuqingchi p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT danghuibing p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT gaosujun p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT wangwei p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT zhouhu p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT chenyuqing p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT maliangming p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT wangjishi p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT zhaopeng p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT yanghaiping p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT zhaoqingwei p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT suoshanshan p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study AT jinjie p1033jaktinibinpatientswithmyelofibrosiswhowererefractoryorrelapsedtoruxolitinibasinglearmopenlabelmulticenterphase2study |